Hyundai Bioscience Co., Ltd. (048410.KQ) KOE
11,320.00
+120(+1.07%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
11,320.00
+120(+1.07%)
Currency In KRW
| Market Cap | 476.84B |
| Enterprise Value | 472.32B |
| P/E Ratio | -51.09 |
| PEG Ratio | 1.13 |
| Price/Sales Ratio | 346.97 |
| Price/Book Ratio | 9.72 |
| Enterprise/Revenue | 349.21 |
| Enterprise/EBITDA | -88.81 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -6.8 |
| Operating Margin | -5.92 |
| Return On Assets | -0.17 |
| Return On Equity | -0.19 |
| Revenue | 3.52B |
| Revenue/Share | 32.59 |
| Gross Profit | -1.03B |
| EBITDA | -16.86B |
| Net Income | -22.13B |
| Diluted EPS | -230.41 |
| Total Cash | 37.8B |
| Total Cash/Share | 393.17 |
| Total Debt | 15.13B |
| Total Debt/Equity | 0.14 |
| Current Ratio | 2.4 |
| Book Value Per Share | 1,164.39 |
| 52-Week Change | 109.05 |
| 52-Week High | 21,500 |
| 52-Week Low | 4,325 |
| Moving Average 50 Days | 13,328.6 |
| Moving Average 200 Days | 8,854.23 |
| Average Volume | 2.91M |
| Shares Outstanding | 96.04M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
| Last Split Date | July 24, 2025 |